Pituitary ACTH Hypersecretion: Clinical Trials

7 trials for Pituitary ACTH Hypersecretion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 active not recruiting, 1 enrolling by invitation. 7 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 3, Recruiting 2, Active not recruiting 1, Enrolling by invitation 1

Follow Pituitary ACTH Hypersecretion: new trials by email Literature Review of Pituitary ACTH Hypersecretion trials Research Report on Pituitary ACTH Hypersecretion

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease
[18F]FET PET-MRI - Cushing Disease
Not applicableEnrolling by invitationUniversity Hospital, Basel, Switzerland432026-06-042026-07-06
DDAVP for Pituitary Adenoma
Desmopressin acetate - Cushing's Disease, Pituitary Adenoma
Not applicableRecruitingNational Institute of Neurological Disorders and Stroke (NINDS)222026-03-092026-04-09
Hair Cortisol and Cushing's Disease
Patient group, Remission control group, Bilateral surrenalectomy control group - Cushing Disease
Not applicableCompletedUniversity Hospital, Bordeaux512021-03-102023-07-18
Postoperative Thrombosis Prevention in Patients With CD
LMWH/Rivaroxaban, IPC - Cushing Disease, DVT
Not applicableActive not recruitingHuashan Hospital2062020-12-012025-07-02
Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders
circadian gene expression evaluation - Cushing Syndrome, Adrenal Insufficiency
Not applicableRecruitingUniversity of Roma La Sapienza442018-07-042026-10-20
Impact of [11C]-Methionine PET/MRI in the Detection of Pituitary Adenomas Secreting ACTH and Causing Cushing's Disease
[11C]-Methionine PET/MRI - Cushing's Disease
Not applicableCompletedHospices Civils de Lyon332017-12-112025-09-25
Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease
Virtual radial task in 3D - Cushing's Disease
Not applicableCompletedInstitut National de la Santé Et de la Recherche Médicale, France302016-02-042025-12-04

Narrower conditions

Addison Disease (1)  ·  Adrenal Insufficiency (1)  ·  Cushing Syndrome (1)  ·  Hypersensitivity (1)  ·  Obesity (1)  ·  Pituitary Neoplasms (1)  ·  Pulmonary Embolism (1)

Broader conditions

Brain Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Endocrine System Diseases (7)  ·  Hyperpituitarism (7)  ·  Hypothalamic Diseases (7)  ·  Nervous System Diseases (7)  ·  Pituitary Diseases (7)  ·  Immune System Diseases (2)  ·  Adrenal Gland Diseases (1)  ·  Adrenocortical Hyperfunction (1)  ·  Autoimmune Diseases (1)  ·  Body Weight (1)  ·  Brain Neoplasms (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Neoplasms (1)

Interventions

Deamino Arginine Vasopressin (1)

Sponsors

Hospices Civils de Lyon (1)  ·  Huashan Hospital (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University Hospital, Bordeaux (1)  ·  University of Roma La Sapienza (1)

Countries

France (3)  ·  China (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Antoine Tabarin, Pr (1)  ·  Prashant Chittiboina, M.D. (1)

Results publications

PMID 36004342, PMID 37144820, PMID 40544300, PMID 40841148, PMID 41760695

NIH funding

2017 (1)